More on Catatonia Schizophrenia

 

1. Neurobiology & Cognitive Impact

Catatonia is not a state of "blankness," but rather a profound disruption in the brain's executive and motor networks:

• Neurotransmitter Dysregulation: Disruptions in dopamine and GABA pathways block the brain's ability to initiate motor commands.

• Executive & Processing Deficits: Severe impairments in working memory, information processing speed, and motor sequencing make simple tasks or communication extremely difficult.

• Hyper-Vigilance: Immobility is frequently an internal "freeze" response to an overwhelming wave of terrifying hallucinations, racing thoughts, or acute terror.

2. Clinical Physical Manifestations

• Stupor: Awakening without voluntary movement or speech.

• Waxy Flexibility: Remaining fixed in positions imposed by others.

• Negativism: Involuntary, automatic resistance to movement or requests.

• Posturing: Spontaneously holding unnatural or uncomfortable positions for extended periods.

3. Comprehensive Two-Step Management Strategy

                               Catatonia Care Strategy
                                          │
                  ┌───────────────────────┴───────────────────────┐
                  ▼                                               ▼
         [ Acute Care Phase ]                            [ Post-Acute Phase ]
       Primary Goal: Stabilization                     Primary Goal: Recovery
  • IV Fluids & Nutritional Support               • Antipsychotics for Psychosis
  • Re-positioning (Prevent DVT/Sores)            • Cognitive Remediation (CRT)
  • Rapid Meds (Lorazepam) or ECT                 • Structured Psychosocial Support

• Acute Phase (Physical Safety): Focuses on emergency medical stabilisation—preventing dehydration, malnutrition, deep vein thrombosis (DVT), and pressure sores. Medications like intravenous/intramuscular lorazepam or Electroconvulsive Therapy (ECT) are used to quickly unlock motor pathways.

• Post-Acute Phase (Cognitive & Psychiatric Stabilisation): Combines antipsychotic therapy to control core schizophrenia symptoms with targeted therapies like Cognitive Remediation Therapy (CRT) and psychosocial support to rebuild memory, attention, and daily living skills.